Science

Aug 12, 2025, 10:24

Myeloma Paper of the Day, August 12th, Suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day:

A case series of GPRC5D bispecific antibody talquetamab-induced dizziness-ataxia syndrome (all patients got 0.8 q2 weeks), including clinical presentation and management suggestions with dexamethasone or cyclophosphamide.”

Title: GPRC5D Bispecific antibody talquetamab-induced dizziness-ataxia syndrome, clinical presentation and management- a case series

Authors: Murali Janakiram, Lawrence Liu, Scott Goldsmith, Azra Borogovac, Sarah Lee, Nitya Nathwani, Michael Rosenzweig, Firoozeh Sahebi, Myo Htut

You can read the Full Article on Blood Cancer Journal.

Myeloma Paper of the Day, August 12th, Suggested by Robert Orlowski

You can find more posts featuring Robert Orlowski on OncoDaily.

Azra Borogovac cancer Cyclophosphamide Firoozeh Sahebi GPRC5D Lawrence Liu Michael Rosenzweig Murali Janakiram Myeloma Myeloma Paper of the Day Myo Htut Nitya Nathwani OncoDaily Oncology Robert Orlowski Sarah Lee Scott Goldsmith

FDA Accepts NDA for Vepdegestrant in ESR1-Mutant ER+/HER2- Advanced Breast Cancer

Hubert Caron Retires from Roche-Genentech

Ramy Sedhom: Palliative Care Isn’t Just about When. It’s about Who, What, and How

Miriam Mutebi: One Small Grant, One Big Difference

Jasmine Kamboj: How We Bring Ourselves to the Table as Leaders